Market Overview:
The global anti-microbial peptides market is expected to grow at a CAGR of 10.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for anti-microbial peptides from various applications such as personal care and cosmetics, healthcare & pharmaceuticals, and biotechnology. In addition, the growing awareness about hygiene and sanitation is also driving the demand for anti-microbial peptides globally. Based on type, the global anti-microbial peptides market can be segmented into plant antimicrobial peptides, bacterial antimicrobial peptides, animal antimicrobial peptides, and insect antimicrobial peptide segments. The plant antimicrobial segment is expected to account for a major share of the global market in 2018 owing to its high efficacy against various types of microorganisms.
Product Definition:
Anti-microbial peptides are a class of naturally occurring, small proteins that have been found to kill or inhibit the growth of microorganisms such as bacteria, fungi and viruses. They are produced by a variety of cells including neutrophils, macrophages, natural killer cells and mast cells. The importance of anti-microbial peptides lies in their ability to protect the body from infection by pathogens.
Plant Anti-Microbial Peptides:
Plant anti-microbial peptides are natural compounds that prevent the growth of microorganisms. These peptides have antimicrobial activity and can be extracted from various plants including, eucalyptus, rosemary, thymol, and cinnamaldehyde.
Bacterial Anti-Microbial Peptides:
Bacterial anti-microbial peptides are also known as bacteriocins. They are naturally occurring antibiotics produced by some bacteria to protect themselves from being infected by other bacteria. Bacteriocins have been found to be effective against a wide range of pathogens, including the causative agents of diseases such as cholera, food poisoning, and tuberculosis.
Application Insights:
The global anti microbial peptides market is segmented by application into personal care and cosmetics, healthcare and pharmaceuticals, food additives, biotechnology and agriculture. Personal care products such as soaps are a common commodity in most countries around the world. They are used for various purposes including skin cleaning, skin softening or moisturizing. The rising importance of hygiene has led to an increase in the demand for antibacterial soaps across the globe which is expected to have a positive impact on market growth over the forecast period.
The increasing prevalence of diseases such as acne vulgaris due to bacterial infection has led researchers from different institutions including Federal University of Minas Gerais (UFMG) develop new ways to treat acne using plant-based antimicrobial agents that do not have any side effects on human health like other conventional treatments do.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period due to increasing awareness regarding personal hygiene and presence of developed healthcare infrastructure. Asia Pacific is projected to be the fastest-growing regional market from 2018 to 2030 owing to rapid economic development, improvement in living standards, and increase in consumer disposable income levels. This has led consumers of this region opt for anti microbial products at a faster pace than other regions.
Growth Factors:
- Increasing incidence of infectious diseases: The increasing incidence of infectious diseases is one of the key growth drivers for the anti microbial peptides market. This is because anti microbial peptides are effective in combating various types of infections caused by bacteria, viruses, and other pathogens.
- Rising demand for novel antibiotics: The growing demand for novel antibiotics is another major factor driving the growth of the anti microbial peptides market. This is because these peptides offer an alternative to conventional antibiotics that are facing resistance from pathogenic microorganisms.
- Growing awareness about benefits of using antimicrobial peptides: There has been a growing awareness about the benefits of using antimicrobial peptides in preventing and treating infections caused by pathogens resistant to conventional antibiotics. This is likely to boost demand for these molecules in the coming years.
Scope Of The Report
Report Attributes
Report Details
Report Title
Anti Microbial Peptides Market Research Report
By Type
Plant Anti-Microbial Peptides, Bacterial Anti-Microbial Peptides, Animal Anti-Microbial Peptides, Insects Anti-Microbial Peptides
By Application
Personal Care and Cosmetics, Healthcare & Pharmaceuticals, Biotechnology
By Companies
AnaSpec, Novozymes, Bachem, Phoenix Biotech, AMP Biotech, Shanghai Abbiochem Company, Ramamoorthy Group, Lytix Biopharma, Ai2, AnaSpec
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
223
Number of Tables & Figures
157
Customization Available
Yes, the report can be customized as per your need.
Global Anti Microbial Peptides Market Report Segments:
The global Anti Microbial Peptides market is segmented on the basis of:
Types
Plant Anti-Microbial Peptides, Bacterial Anti-Microbial Peptides, Animal Anti-Microbial Peptides, Insects Anti-Microbial Peptides
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Personal Care and Cosmetics, Healthcare & Pharmaceuticals, Biotechnology
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- AnaSpec
- Novozymes
- Bachem
- Phoenix Biotech
- AMP Biotech
- Shanghai Abbiochem Company
- Ramamoorthy Group
- Lytix Biopharma
- Ai2
- AnaSpec
Highlights of The Anti Microbial Peptides Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Plant Anti-Microbial Peptides
- Bacterial Anti-Microbial Peptides
- Animal Anti-Microbial Peptides
- Insects Anti-Microbial Peptides
- By Application:
- Personal Care and Cosmetics
- Healthcare & Pharmaceuticals
- Biotechnology
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Anti Microbial Peptides Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Anti-microbial peptides are a type of protein that helps to fight against bacteria and other microorganisms. They can be found in many different types of products, including personal care products, food items, and pharmaceuticals.
Some of the major companies in the anti microbial peptides market are AnaSpec, Novozymes, Bachem, Phoenix Biotech, AMP Biotech, Shanghai Abbiochem Company, Ramamoorthy Group, Lytix Biopharma, Ai2, AnaSpec.
The anti microbial peptides market is expected to grow at a compound annual growth rate of 10.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Anti Microbial Peptides Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Anti Microbial Peptides Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Anti Microbial Peptides Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Anti Microbial Peptides Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Anti Microbial Peptides Market Size & Forecast, 2018-2028
4.5.1 Anti Microbial Peptides Market Size and Y-o-Y Growth
4.5.2 Anti Microbial Peptides Market Absolute $ Opportunity
Chapter 5 Global Anti Microbial Peptides Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Anti Microbial Peptides Market Size Forecast by Type
5.2.1 Plant Anti-Microbial Peptides
5.2.2 Bacterial Anti-Microbial Peptides
5.2.3 Animal Anti-Microbial Peptides
5.2.4 Insects Anti-Microbial Peptides
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Anti Microbial Peptides Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Anti Microbial Peptides Market Size Forecast by Applications
6.2.1 Personal Care and Cosmetics
6.2.2 Healthcare & Pharmaceuticals
6.2.3 Biotechnology
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Anti Microbial Peptides Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Anti Microbial Peptides Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Anti Microbial Peptides Analysis and Forecast
9.1 Introduction
9.2 North America Anti Microbial Peptides Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Anti Microbial Peptides Market Size Forecast by Type
9.6.1 Plant Anti-Microbial Peptides
9.6.2 Bacterial Anti-Microbial Peptides
9.6.3 Animal Anti-Microbial Peptides
9.6.4 Insects Anti-Microbial Peptides
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Anti Microbial Peptides Market Size Forecast by Applications
9.10.1 Personal Care and Cosmetics
9.10.2 Healthcare & Pharmaceuticals
9.10.3 Biotechnology
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Anti Microbial Peptides Analysis and Forecast
10.1 Introduction
10.2 Europe Anti Microbial Peptides Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Anti Microbial Peptides Market Size Forecast by Type
10.6.1 Plant Anti-Microbial Peptides
10.6.2 Bacterial Anti-Microbial Peptides
10.6.3 Animal Anti-Microbial Peptides
10.6.4 Insects Anti-Microbial Peptides
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Anti Microbial Peptides Market Size Forecast by Applications
10.10.1 Personal Care and Cosmetics
10.10.2 Healthcare & Pharmaceuticals
10.10.3 Biotechnology
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Anti Microbial Peptides Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Anti Microbial Peptides Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Anti Microbial Peptides Market Size Forecast by Type
11.6.1 Plant Anti-Microbial Peptides
11.6.2 Bacterial Anti-Microbial Peptides
11.6.3 Animal Anti-Microbial Peptides
11.6.4 Insects Anti-Microbial Peptides
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Anti Microbial Peptides Market Size Forecast by Applications
11.10.1 Personal Care and Cosmetics
11.10.2 Healthcare & Pharmaceuticals
11.10.3 Biotechnology
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Anti Microbial Peptides Analysis and Forecast
12.1 Introduction
12.2 Latin America Anti Microbial Peptides Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Anti Microbial Peptides Market Size Forecast by Type
12.6.1 Plant Anti-Microbial Peptides
12.6.2 Bacterial Anti-Microbial Peptides
12.6.3 Animal Anti-Microbial Peptides
12.6.4 Insects Anti-Microbial Peptides
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Anti Microbial Peptides Market Size Forecast by Applications
12.10.1 Personal Care and Cosmetics
12.10.2 Healthcare & Pharmaceuticals
12.10.3 Biotechnology
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Anti Microbial Peptides Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Anti Microbial Peptides Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Anti Microbial Peptides Market Size Forecast by Type
13.6.1 Plant Anti-Microbial Peptides
13.6.2 Bacterial Anti-Microbial Peptides
13.6.3 Animal Anti-Microbial Peptides
13.6.4 Insects Anti-Microbial Peptides
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Anti Microbial Peptides Market Size Forecast by Applications
13.10.1 Personal Care and Cosmetics
13.10.2 Healthcare & Pharmaceuticals
13.10.3 Biotechnology
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Anti Microbial Peptides Market: Competitive Dashboard
14.2 Global Anti Microbial Peptides Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 AnaSpec
14.3.2 Novozymes
14.3.3 Bachem
14.3.4 Phoenix Biotech
14.3.5 AMP Biotech
14.3.6 Shanghai Abbiochem Company
14.3.7 Ramamoorthy Group
14.3.8 Lytix Biopharma
14.3.9 Ai2
14.3.10 AnaSpec
